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ABSTRACT
We report the occurrence of congenital toxoplasmosis in three infants born to HIV infected women 
who had high anti-toxoplasma IgG and negative IgM during pregnancy. We brieﬂ y reviewed avail-
able literature and discussed the possible transmission mechanisms of congenital toxoplasmosis 
among HIV infected pregnant women. Serum samples were tested for Toxoplasma gondii IgM and 
IgG antibodies using commercial enzyme immunoassay and IgG-avidity tests. In the fi rst case, fetal 
death occurred at 28th week of gestation. In the second case, congenital toxoplasmosis was diagnosis 
at 6th month of life; and in the third case, an HIV-infected newborn, congenital toxoplasmosis was 
asymptomatic. These cases point out to the possibility of enhanced maternal-fetal transmission of 
T. gondii infection by HIV-infected women chronically infected, which may have important pub-
lic health consequences, considering that increasing frequency of HIV-infection has been observed 
among women of childbearing age around the world.
Keywords: congenital toxoplasmosis, human immunodefi ciency-virus, prevention, AIDS.
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INTRODUTION
Toxoplasma gondii is a ubiquitous obligatory 
widely-distributed intracellular protozoan. Once 
infected, the host normally acquires lifelong im-
munity induced by the persistence of the para-
site in an encysted form. Maternal immunity ap-
pears to protect against fetal infections. If anti-T. 
gondii IgG antibody is confi rmed before preg-
nancy, then the woman is not at risk for a con-
genitally infected fetus. Congenital toxoplasmo-
sis is usually the result of maternal acquisition 
of T. gondii for the fi rst time during gestation.1 
However, vertical transmission of toxoplasmo-
sis as a result of reactivation has been described 
in immunocompromised women2-4 and more 
rarely in immunocompetent women.5
Clinical manifestations of congenital toxo-
plasmosis are numerous, including intracranial 
calcifi cations, convulsion, psychomotor retar-
dation, strabismus, chorioretinitis, microceph-
aly, and hydrocephaly observed in infancy or 
later. However, most neonates with congenital 
toxoplasmosis are asymptomatic or with sub-
clinical presentation of the disease at birth.6
There is limited data on medical literature 
about the frequency of T. gondii vertical trans-
mission among HIV-infected women.7-10 In 
Brazil, the prevalence of seropositivity for T. 
gondii is 50% to 80% in women of childbearing 
age.11-15 Although T. gondii infection is highly 
prevalent in Brazil, there are only two reports 
of congenital toxoplasmosis documented 
among HIV-infected women.8,16
In this paper we describe serological and 
clinical fi ndings of three cases of congenital 
toxoplasmosis diagnosed among 113 HIV-ex-
posed infants followed at the Infectious Diseases 
Department of Antônio Pedro University Hospi-
tal, since 1998, in Niterói, Rio de Janeiro, Bra-
zil. Seventy per cent of HIV-infected mothers 
had serologic evidence of anti-T. gondii IgG 
during pregnancy. Blood samples were taken 
serially for HIV routine diagnostic purpos-
es, and some serum samples from the three 
patients were tested retrospectively for the 
present study.
CASES REPORT
First case: A 26-year-old caucasian woman 
was diagnosed with HIV-infection in May 
2004, at 14 weeks’ gestation of her third preg-
nancy. Routine prenatal testing revealed An-
ti-T. gondii IgG positive and anti-T. gondii IgM 
negative. She was asymptomatic and had never 
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been treated with antiretroviral drugs. Initial CD4 cell count 
was 291/mm³ and viral load was 65,000 copies/mL (4.81 
log) by nucleic acid sequence based amplifi cation (NASBA). 
From the 22nd week of gestation onwards, she was started 
on zidovudine, lamivudine and nevirapine for prophylaxis 
of HIV-infection vertical transmission. At 21 weeks’ gesta-
tion (July 2004) another toxoplasma serology was done and 
the result revealed IgG positive (2,320 IU/mL; cut-off: 8 IU/
mL) and IgM negative by enzyme linked ﬂ uorescent assay 
(ELFA) (VIDAS® Toxo IgG II and IgM, Biomérieux SA, 
France). The anti-T. gondii IgG-avidity was high (0.586; cut-
off: 0.3) (VIDAS® Toxo IgG Avidity, Biomérieux SA). At 28 
weeks’ gestation (August 2004), she was admitted to the hos-
pital with fever, ﬂ ank pain, and pyuria. She received cefazo-
line for treatment of urinary tract infection. Her laboratory 
exams showed anaemia, and toxoplasma serology was posi-
tive for IgG (2,488 IU/mL) and negative for IgM antibodies 
by ELFA. Ultrasonography revealed fetal death and delivery 
was induced. Fetal autopsy showed hepatosplenomegaly 
and anasarca. Microscopic analysis of heart sections stained 
with hematoxylin and eosin (HE) revealed pericarditis and 
myocarditis, with acute and chronic inﬂ ammatory infi ltra-
tion and micro-elements morphologically compatible with 
T. gondii trophozoites. Placental histology showed diffuse 
necrotizantis villositis with trophozoites. Immunostaining 
with polyclonal antibody anti-T. gondii (rabbit anti-T. gon-
dii; code no.: B1013, Dako, Denmark) of heart and placenta 
tissue sections confi rmed HE microscopic analysis. Her tox-
oplasma serology repeated in October 2004 was positive for 
IgG antibodies (2,262 IU/mL) by ELFA. Six months after, 
the IgG titre by ELFA was lower (1,232 IU/mL). Both sera 
were negative with the IgM-ELFA and showed high avidity 
IgG antibodies.
Second case: A 30-year-old caucasian woman was di-
agnosed with HIV-infection in September 2005, on the 
12th week of her third pregnancy. Routine prenatal testing 
revealed anti-T. gondii IgG positive (1/512; cut-off: 1/16) 
and IgM negative by EIA. Eight months before this pregnan-
cy, she had done a toxoplasma serology with equal result. 
In November 2005, on the 20th week of gestation, she was 
asymptomatic and her CD4 cell count was 147/mm³ and 
the viral load was 750 copies/mL (2.87 log) by NASBA. Her 
toxoplasma serology was positive for IgG (364 IU/mL) and 
negative for IgM by ELFA. The VIDAS IgG-avidity test was 
high (0.620). From the 21th week of gestation onwards, she 
was started on zidovudine, lamivudine, and nevirapine for 
treatment and also for prophylaxis of HIV-infection verti-
cal transmission. At 32 weeks’ gestation (February 2006), her 
CD4 count was 213/mm³, viral load was below 80 copies/
mL by NASBA and toxoplasma serology was positive for IgG 
antibodies (476 IU/mL) and negative for IgM by ELFA. The 
VIDAS IgG-avidity test was high (0.519). At 39 weeks’ gesta-
tion (March 2006), she was submitted to a cesarean-sec-
tion because of fetal suffering. An apparently healthy girl 
was born, and zidovudine was given to the newborn for 6 
weeks to prevent HIV infection. The baby was followed up 
by the Pediatric Department and in June 2006 she started 
presenting nistagmus. On clinical exam there were stra-
bismus, neurodevelopmental delay and hepatosplenom-
egaly. Laboratory screening revealed anti-T. gondii IgG 
(107 IU/mL) and a positive IgM by ELFA. Funduscopy 
showed chorioretinitis in her left eye and the skull radiog-
raphy was normal. The child was treated with sulfadiazine, 
pirimetamine, and folinic acid for 6 months. During fol-
low-up visits, chorioretinal scars were seen in funduscopic 
reevaluation and intracranial calcifi cations on brain CT 
scan. Anti-T. gondii serology by ELFA revealed IgG positive 
(99 IU/mL) and IgM negative. The child had a serology for 
HIV negative at the 11th month of life, being considered 
HIV-uninfected. Placenta histology showed intervillositis, 
extensive villitis and chorioamnionitis. 
Retrospectively, the mother’s serology showed a signifi -
cant increase in Anti-T. gondii IgG titre by ELFA from 364 
IU/mL in November 2005 to 3,616 IU/mL in March 2006. 
Both sera were negative with the IgM-ELFA and had high 
avidity IgG antibodies. During follow-up visits, maternal 
anti-T. gondii serology still showed high levels of IgG an-
tibodies detected by ELFA: July 2006 – IgG: 6,138 IU/mL; 
January 2007 – IgG: 2,970 IU/mL; October 2007 – IgG: 
2,188 IU/mL. All serum samples tested for IgM antibodies 
by ELFA were negative and also had high avidity IgG anti-
bodies anti-T. gondii.
Third case: A 16-year-old afro-descend adolescent was 
diagnosed with HIV-infection in 2003 during her fi rst preg-
nancy. Her follow-up visits were at irregular intervals, and 
antiretrovirals were given only for prophylaxis of HIV-infec-
tion vertical transmission during pregnancy. Her toxoplas-
ma serology had always been positive for IgG and negative 
for IgM antibodies since 2003. In February 2008, she sought 
for medical advice as she was at 33 weeks’ gestation. She had 
pruritus, anaemia, and her toxoplasma serology was positive 
for IgG antibodies (204 IU/mL) and inconclusive for IgM by 
ELFA. In March 2008 (36 weeks’ gestation), she complained 
of progressive visual impairment affecting the left eye, and 
ophthalmologic examination showed uveitis due to toxo-
plasmosis. Her toxoplasma serology was positive for IgG an-
tibodies (198 IU/mL) and negative for IgM by ELFA. The VI-
DAS IgG-avidity test was high (0.391). She was treated with 
sulfadiazine, pirimetamine, and folinic acid for ocular toxo-
plasmosis and zidovudine for prophylaxis of HIV-infection 
vertical transmission. Her CD4 cell count was 171/mm³ and 
the viral load was 333,129 copies/mL (5.523 log) by b-DNA 
technique. She was submitted to an elective cesarean-section 
at 38 weeks’ gestation. A healthy girl was born, and labora-
tory showed toxoplasma serology positive for IgG antibodies 
(172 IU/mL) and positive for IgM by ELFA. Cerebrospinal 
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ﬂ uid examination reveled pleocytosis (20 cell/mm³, 100% 
neutrophil predominance), elevated protein (129 mg/dL). 
Funduscopy and skull radiography were normal. The child 
was discharged from hospital receiving drugs for treatment 
of congenital toxoplasmosis and to prevent HIV infection. 
The baby was followed up by the Pediatric Department. In 
May 2008, her HIV viral load was positive (163,000 cop-
ies/mL; 5.21 log) by b-DNA technique. In June 2008, she 
had oral candidiasis and her CD4 cell count and viral load 
were, respectively, 1,407/mm³ and more than 500,000 cop-
ies/mL. Her clinical and laboratorial status was compatible 
with aids, and antiretroviral treatment was started in July 
2008.
DISCUSSION
Although not proved, our fi rst case was possibly a reactiva-
tion of latent T. gondii infection. There was a possibility of 
acquired infection in the fi rst 14 weeks of gestation; since 
absence of specifi c IgM is characteristic for HIV-infected 
patients.8 Fetal death may support this hypothesis of newly 
acquired infection. However, the sharp rise in specifi c IgG 
suggests remote infection, because in HIV-infected patients 
the serum levels of antibodies against existing infections 
increase, but the humoral response to recently introduced 
antigens decreases.17 
Our fi rst case indicates that congenital toxoplasmosis 
may occur in children of HIV-positive mothers who are not 
severely immunocompromised as a result of toxoplasmic re-
activation. Even though no serology to T. gondii infection 
was available before the present gestation, negative IgM and 
high IgG-avidity antibodies are compatible with primary in-
fection before the pregnancy, although HIV-infected preg-
nant women may present newly acquired T. gondii infection 
without seroconvertion to specifi c IgM.9 The other two cases 
were both severely immunocompromised and their antibody 
test results clearly showed T. gondii infection acquired before 
pregnancy. In the three cases, congenital toxoplasmosis was 
probably due to reactivation of latent maternal infection, al-
though reinfection with a different strain of T. gondii is also 
possible.2
The second case alerts for the necessity of doing tests for 
congenital infections in newborns of HIV-infected mothers. 
The opportunity of treating infant since birth, or even before 
birth, must not be lost. This case, in which CT scan showed 
intracerebral calcifi cations, alerts to very low sensitivity of 
skull radiography to congenital toxoplasmosis.18 This infant 
was treated for only 6 months because when she was 1-year-
old there were no signs of active infection. 
Although HIV-infected pregnant women chronically 
infected with T. gondii may transmit the infection to the 
fetus, the risk is low and certainly less than 5%.7,8,10 Some 
authors advocate that women with CD4 less than 100 cells/
mm³ who are Anti-T. gondii IgG positive should be treated 
with adequate prophylaxis during pregnancy to attempt 
to interrupt transmission of T. gondii from chronically in-
fected women to fetus. They suggest this advice may be also 
appropriate for HIV-uninfected patients who are severely 
immunocompromised for other reason.10 Other study sug-
gests that the risk of maternal-fetal transmission is not suf-
fi cient high to justify routine anti-toxoplasmosis chemo-
prophylaxis for HIV-infected pregnant women, although 
the authors highlight the need of further research on this 
issue.7 
The lack of an established risk of maternal-fetal infec-
tion, particularly in countries like Brazil where there are 
high seroprevalence rates of T. gondii, may explain the cur-
rent obstetric management of these patients without the 
prescription of anti-toxoplasmosis chemoprophylaxis in 
chronically infected women. 
Our report shows the need for special attention to ma-
ternal titles of anti-T. gondii antibodies during HIV prena-
tal care even in women chronically infected with T. gondii 
and also in those not severely immunocompromised. A 
high concentration of T. gondii-specifi c IgG and a positive 
result for T. gondii-specifi c IgM in immunocompetent pa-
tients usually indicate recent infection, because T. gondii-
specifi c IgG increases rapidly in the acute infection. Con-
versely, a low concentration of T. gondii-specifi c IgG and no 
T. gondii-specifi c IgM is a sign a remote infection.19 These 
indications may not apply to HIV-infect pregnant women. 
If, as described for HIV-infected patients in general,17 it is 
true for HIV-infected pregnant women, the serum levels of 
antibodies against existing infections increase and the hu-
moral response to recently introduced antigens decreases, 
then, high T. gondii-specifi c IgG concentrations may, para-
doxically, indicate latent T. gondii infection, whereas low 
concentrations may indicate recent infection, when the 
risk of congenital toxoplasmosis may be high. A higher risk 
of congenital toxoplasmosis with low T gondii-specifi c IgG 
concentration and negative specifi c IgM is worth of atten-
tion in order to not let a case of acute gestational toxoplas-
mosis unidentifi ed in HIV-infected pregnant women. It 
also enhances the relevance of routine antibody screening 
for congenital toxoplasmosis in the newborn blood. The 
screening for IgM antibody is an important tool for the 
detection of newborns infected with T. gondii20 and it is 
mandatory in HIV-exposed infants.2 
Considering the increasing frequency that HIV-in-
fection has been observed among women of childbear-
ing age around the world and the severity of fetal lesions 
caused by congenital toxoplasmosis, the possibility of 
enhanced maternal-fetal transmission of this infection 
by HIV-infected women chronically infected with T. 
gondii may have important public health consequences, 
mainly in those countries with high seroprevalence rates 
of T. gondii infection. 
Congenital toxoplasmosis infection
189Braz J Infect Dis 2010; 14(2):186-189
Azevedo, Setúbal, Lopes et al.
ACKNOWLEDGEMENTS
We would like to thank Dr. Rosa Vieira and her team, 
from the Immunology Laboratory, Hospital Universitário 
Antônio Pedro (UFF), for carrying out the serological tests 
for toxoplasmosis.
 
REFERENCES
1. American College of Obstetricians and Gynecologists. Perina-
tal viral and parasitic infections. ACOG Pract Bull 2000; 20.
2. Bachmeyer C, Mouchnino G, Thulliez P, Blum L. Congenital 
toxoplasmosis from an HIV-infected woman as a result of re-
activation. J Infect 2006; 52:e55-e57.
3. Mitchell CD, Erlich SS, Mastrucci MT et al. Congenital toxo-
plasmosis occurring in infants perinatally infected with human 
immunodefi ciency virus 1. Pediatr Infect Dis J 1990; 9:512-8.
4. Marty P, Bongain A, Loiseau S et al. Lethal congenital toxoplas-
mosis resulting from reactivation of toxoplasmosis in a preg-
nant HIV-positive patient. Presse Med 2002; 31:1558.
5. Kodjikian L, Hoigne I, Adam O et al. Vertical transmission of 
toxoplasmosis from a chronically infected immunocompetent 
woman. Pediatr Infect Dis J 2004; 23(3):272-4.
6. Sáfadi MA, Berezin EN, Farhat CK, Carvalho ES. Clinical pres-
entation and follow up of children with congenital toxoplas-
mosis in Brazil. Braz J Infect Dis 2003; 7(5):325-31.
7. European Colaborative Study and Research Network on Congen-
ital Toxoplasmosis. Low incidence of congenital toxoplasmosis in 
children born to women infected with human immunodefi ciency 
virus. Eur J Obstet Gynecol Reprod Bio 1996; 68:93-6.
8. Lago EG, Conrado GS, Piccoli CS, Carvalho RL, Bender AL. 
Toxoplasma gondii antibody profi le in HIV-infected pregnant 
women and the risk of congenital toxoplasmosis. Eur J Clin 
Microbiol Infect Dis 2008; [epud ahead of print].
9. Nogueira SA, Machado ES, Costa TP et al. Co-infection with 
Toxoplasma gondii in a cohort of HIV infected pregnant wom-
en. Proceedings of the International AIDS Conference, Barce-
lona, Spain. July 2002.
10. Minkoff H, Remington JS, Holman SRN et al. Vertical trans-
mission of toxoplasma by human immunodefi ciency virus in-
fected women. Am J Obstet Gynecol 1997; 176:555-9.
11. Mandai ON, Lopes FMR, Breganó RM. Prevalence of an-
tibodies IgG and IgM anti-Toxoplasma gondii in pregnant 
women assisted in the unidades básicas de saúde of Lond-
rina – Paraná, in the period of 2003 and 2004. RBAC 2007; 
39(4):247-9.
12. Areal KR, Miranda AE. Seroprevalence of toxoplasmosis in 
pregnant women attending primary health care in Vitória, ES. 
NewsLab 2008; 87:122-9.
13. Porto AMF, Amorim MMR, Coelho ICN, Santos LC. Sero-
logic profi le of toxoplasmosis in pregnant women attend-
ed at a teaching-hospital in Recife. Rev Ass Med Bras 2008; 
54(3):242-8.
14. Heukelbach J, Meyer-Cirkel V, Moura RCS et al. Waterborne 
toxoplasmosis, Northeastern Brazil. Emerg Infect Dis 2007; 
13(2):287-9.
15. Galisteu KF, Mattos CB, Lelis AGL et al. Prevalence and risk 
factors associated with toxoplasmosis in pregnant women and 
their children in the Northwest of São Paulo State, Brazil. Rev 
Panam Infectol 2007; 9(4):24-9.
16. Cruz MLS, Cardoso CAC, Saavedra MC, Santos ED, Melino 
T. Congenital toxoplasmosis infection in an infant born 
to an HIV-1-infected mother. Braz J Infect Dis 2007; 
11(6):610-1.
17. Fauci AS. The human immunodefi ciency virus: infectivity and 
mechanisms of pathogenesis. Science 1988; 617:617-22.
18. Lebech M, Joynson DH, Seitz HM et al. Classifi cation system 
and case defi nitions of Toxoplasma gondii infection in immu-
nocompetent pregnant women and their congenitally infected 
offspring. Eur J Clin Microbiol Infect Dis 1996; 15:799-805.
19. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infec-
tion and toxoplasmosis. J Infect Dis 2002; 185(Suppl 1):S73-
S82.
20. Mozzato L, Procioanoy RS. Incidence of congenital toxoplas-
mosis in southern Brazil: a prospective study. Rev Inst Med 
trop S. Paulo 2003; 45(3):147-52.
